Latest return on equity
Vistagen Therapeutics Return on equity
Direct answer
Vistagen Therapeutics's return on equity is -166.46%.
The verified market snapshot reports -166.46%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 20, 2026.
Get free Vistagen Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -166.46%
Explore related company data
View Vistagen Therapeutics's market capitalizationView Vistagen Therapeutics's price-to-book ratioView Vistagen Therapeutics's dividend yieldView Vistagen Therapeutics's 52-week price rangeView Vistagen Therapeutics's revenue growthView Vistagen Therapeutics's profit marginView Vistagen Therapeutics's debt-to-equity ratioView all Vistagen Therapeutics key metricsReturn to Vistagen Therapeutics profile